PMID: 8582997Jul 1, 1995Paper

In-vitro fertilization pregnancies and perinatal health in Finland 1991-1993

Human Reproduction
M GisslerE Hemminki

Abstract

In 1993, in Finland at least 0.7% of all pregnancies ending in birth were assisted by in-vitro fertilization (IVF). The purpose of this study was to compare IVF mothers with other mothers, and the perinatal health and health care costs of IVF infants to those of other infants. The main source of information was the Medical Birth Register for 1991-1993 (n = 19,1712 pregnancies, of which 1015 were started by IVF). IVF mothers were more often older, married and primiparas. They started antenatal care earlier, had more visits than other mothers and more than 50% were hospitalized during their pregnancy. Every fourth IVF pregnancy was a multiple one. Both IVF singletons and multiples had poorer health than other infants. The new practice of implanting fewer embryos than before was introduced in 1992-1993, and a 50% decrease in triplet rate was found. At the same time, a somewhat better outcome for IVF newborns was found. However, every fourth child was still preterm or weighed < 2500 g. The health care costs for one IVF newborn from induction of pregnancy until the age of 7 days was 5.4-fold compared to other newborns. The subsequent health of IVF children has to be further studied to more fully assess the health impact of IVF.

Citations

Jan 25, 2005·Human Reproduction·Christina Bergh
Oct 4, 2005·Obstetrics and Gynecology·Hamisu M SalihuRussell S Kirby
Aug 27, 2005·Human Reproduction Update·Anja Pinborg
Apr 4, 2009·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·Philipa Mladovsky, Corinna Sorenson
Aug 7, 1999·Human Reproduction·S Nuojua-HuttunenL Tuomivaara
Oct 18, 2002·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·C L RobertsD J Henderson-Smart
Apr 25, 2000·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·K TunónJ A Kahn
Feb 28, 2006·Human Reproduction·Petra De SutterMarc Dhont
Dec 12, 2003·Medical Informatics and the Internet in Medicine·Elina HemminkiJaana Martikainen
Mar 8, 2002·The New England Journal of Medicine·Laura A SchieveLynne S Wilcox
Apr 9, 2004·BMC Medical Informatics and Decision Making·Mika GisslerElina Hemminki
Sep 25, 2004·Human Reproduction·S KoivurovaM-R Järvelin
Nov 25, 2005·Acta Obstetricia Et Gynecologica Scandinavica·Bengt KällénPetra Otterblad Olausson
Feb 18, 2005·Journal of Psychosomatic Obstetrics and Gynaecology·D UlrichH Kentenich
Mar 26, 2005·Human Reproduction·Petra De SutterMarc Dhont
Mar 30, 2004·Reproductive Medicine and Biology·Takeshi KuramotoRajadurai Rajamahendran
Feb 25, 2011·Fetal Diagnosis and Therapy·Petya ChaveevaKypros H Nicolaides
Feb 15, 2002·Human Fertility : Journal of the British Fertility Society·Ulla-Britt Wennerholm, Christina Bergh
Jul 2, 2004·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·S SaltvedtC Grunewald
Jul 29, 2005·Journal of Assisted Reproduction and Genetics·Dan HellbergStaffan Nilsson
Dec 3, 2004·The New England Journal of Medicine·Ann ThurinChristina Bergh
Mar 3, 2004·Obstetrics and Gynecology·Rebecca A JacksonMary S Croughan
Jul 21, 2021·American Journal of Perinatology·Jeani ChangUNKNOWN for States Monitoring Assisted Reproductive Technology (SMART) Collaborative
Oct 6, 2005·Reproductive Biology and Endocrinology : RB&E·Mohamed F M MitwallyMichael P Diamond

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.